A10 (Ampyra 10 mg)
Generic Name: dalfampridine
Pill imprint A10 has been identified as Ampyra 10 mg.
Ampyra is used in the treatment of multiple sclerosis and belongs to the drug class miscellaneous central nervous system agents. Risk cannot be ruled out during pregnancy. Ampyra 10 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- dalfampridine
- Imprint:
- A10
- Strength:
- 10 mg
- Color:
- White
- Size:
- 13.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous central nervous system agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Acorda Therapeutics Inc.
- National Drug Code (NDC):
- 10144-0427
- Inactive Ingredients:
- hypromelloses
microcrystalline cellulose
silicon dioxide
magnesium stearate
titanium dioxide
polyethylene glycol
Note: Inactive ingredients may vary.
More about Ampyra (dalfampridine)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 52 Reviews – Add your own review/rating
- Generic Availability
- Drug class: miscellaneous central nervous system agents
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
